Functional Redundancy of Human Microbiome and its Implication in Fecal Microbiota Transplantation
人类微生物组的功能冗余及其在粪便微生物移植中的意义
基本信息
- 批准号:10668456
- 负责人:
- 金额:$ 89.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:BehaviorClinicalClinical ResearchClostridium difficileCommunitiesComplexDataData AnalysesDiseaseEcologyEcosystemEngraftmentGastrointestinal DiseasesGenomicsGoalsHealthHumanHuman MicrobiomeInfectionInflammatory Bowel DiseasesIrritable Bowel SyndromeKnowledgeMeasuresMedicalMetagenomicsMethodsMissionModificationNatureNetwork-basedObesityOrganismOutcomePatientsPhylogenetic AnalysisPhysiologyPlayPopulationProbabilityPublic HealthRecurrenceResearchResistanceRoleSamplingSystemTaxonomyTestingTherapeutic InterventionTranslatingUnited States National Institutes of HealthWhole-Genome Shotgun SequencingWorkautism spectrum disorderdysbiosiseffective therapyfecal transplantationgut microbiomegut microbiotaimprovedinnovationmicrobial communitymicrobiomemicrobiotamicrobiota transplantationmicroorganismmodels and simulationnovel strategiesresiliencestool samplesuccesstranslational impact
项目摘要
Project Summary
Commensal microorganisms play critical roles in human physiology and diseases. Despite rapidly
expanding knowledge of the composition of the human gut microbiota, our understanding of the
ecological principles that govern the assembly and resilience of the highly complex and dynamic
ecosystem of the gut microbiota is rudimentary. This knowledge gap becomes more problematic as new
approaches to modify the microbiota, such as fecal microbiota transplantation (FMT), are being
developed as therapeutic interventions. The overall objective of the proposed studies is to construct an
ecological framework to understand the efficacy of FMT in treating recurrent C. difficile infection (rCDI) at
the systems level. The central hypothesis is that the functional redundancy of the recipient’s pre-FMT
microbiota can be used to predict the extent of donor microbiota engraftment and predict the efficacy of
FMT. As a classical concept in ecology, functional redundancy (FR) means that phylogenetically
unrelated species perform similar functions in ecosystems so that they can be interchanged with little
impact on the overall ecosystem functioning. The rationale for the proposed research is that
understanding the efficacy of FMT in treating rCDI has the potential to translate into better understanding
of its efficacy in treating a variety of other diseases associated with disrupted microbiomes. Guided by
strong preliminary data, the central hypothesis will be tested by pursuing three specific aims: 1) Develop
a network-based method to quantify the within-sample FR of human microbiome samples. The
applicant’s preliminary results suggest that the FR of a microbiome sample can be calculated from its
taxonomic profile and a reference genomic content network. 2) Develop an ecological framework to study
the relationship between the FR of a microbial community and its resistance to new species. The working
hypothesis is that the higher the within-sample FR of a microbial community, the more resistant it is
against species addition, e.g., through FMT. Both ecological modeling/simulations and real data analysis
will be performed to verify this hypothesis. 3) Clinical study to test that FMT has a lower efficacy in
treating rCDI patients with higher FR in their pre-FMT microbiota. Stool samples from the recipients and
their respective donors will be collected for metagenomic whole genome shotgun sequencing.
Subsequently, the relationships among the FR of the recipients’ pre-FMT microbiota, the engraftment of
donor-specific species in the recipients’ post-FMT microbiota, and the FMT efficacy will be quantitatively
analyzed. The approach is innovative because it shifts focus from specific taxa or functions to a systems
level understanding of the human gut microbiome using network and ecological approaches. The
proposed research is significant because it will improve our understanding on the ecological principles of
FMT for rCDI as well for other conditions associated with disrupted microbiomes.
项目总结
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Structured community transitions explain the switching capacity of microbial systems.
结构化群落转变解释了微生物系统的转换能力。
- DOI:10.1073/pnas.2312521121
- 发表时间:2024
- 期刊:
- 影响因子:11.1
- 作者:Long,Chengyi;Deng,Jie;Nguyen,Jen;Liu,Yang-Yu;Alm,EricJ;Solé,Ricard;Saavedra,Serguei
- 通讯作者:Saavedra,Serguei
Removal of false positives in metagenomics-based taxonomy profiling via targeting Type IIB restriction sites.
- DOI:10.1038/s41467-023-41099-8
- 发表时间:2023-09-01
- 期刊:
- 影响因子:16.6
- 作者:Sun, Zheng;Liu, Jiang;Zhang, Meng;Wang, Tong;Huang, Shi;Weiss, Scott T.;Liu, Yang-Yu
- 通讯作者:Liu, Yang-Yu
Gut feelings: associations of emotions and emotion regulation with the gut microbiome in women.
- DOI:10.1017/s0033291723000612
- 发表时间:2023-11
- 期刊:
- 影响因子:6.9
- 作者:Ke, Shanlin;Guimond, Anne-Josee;Tworoger, Shelley S.;Huang, Tianyi;Chan, Andrew T. T.;Liu, Yang-Yu;Kubzansky, Laura D. D.
- 通讯作者:Kubzansky, Laura D. D.
Establishment and resilience of transplanted gut microbiota in aged mice.
老年小鼠移植肠道微生物群的建立和恢复能力
- DOI:10.1016/j.isci.2021.103654
- 发表时间:2022-01-21
- 期刊:
- 影响因子:5.8
- 作者:Wang Y;Tang J;Lv Q;Tan Y;Dong X;Liu H;Zhao N;He Z;Kou Y;Tan Y;Liu XA;Wang L;Liu YY;Dai L
- 通讯作者:Dai L
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yang-Yu LIU其他文献
Yang-Yu LIU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yang-Yu LIU', 18)}}的其他基金
Functional Redundancy of Human Microbiome and its Implication in Fecal Microbiota Transplantation
人类微生物组的功能冗余及其在粪便微生物移植中的意义
- 批准号:
10460355 - 财政年份:2019
- 资助金额:
$ 89.43万 - 项目类别:
Functional Redundancy of Human Microbiome and its Implication in Fecal Microbiota Transplantation
人类微生物组的功能冗余及其在粪便微生物移植中的意义
- 批准号:
10226202 - 财政年份:2019
- 资助金额:
$ 89.43万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 89.43万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 89.43万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 89.43万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 89.43万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 89.43万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 89.43万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 89.43万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 89.43万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 89.43万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 89.43万 - 项目类别: